Fig. 3.

IOP in non-rescued eyes after a single administration of 10-µg bimatoprost implant or once-daily topical bimatoprost 0.03% through month 24 in the phase 1/2 study. The analysis used observed values for eyes that had not received any rescue IOP-lowering treatment or a second administration of implant. Values shows are mean ± SD. The differences between groups (study eye minus fellow eye) and 95% CIs of the differences were calculated using paired t tests. CI confidence interval, H hour, IOP intraocular pressure, SD standard deviation